Life science specialists, AMSBIO, have made a new strategic investment to enhance the level of support to its sizeable and growing base of customers across the European Union.

Malvern Panalytical has announced its acquisition of Creoptix AG, a specialist bioanalysis sensor company. The acquisition forms a critical part of Malvern Panalytical’s strategy to expand its capabilities in support of drug discovery.

AMSBIO has announced new additions to its portfolio of tools for COVID-19 research - two monoclonal antibodies that recognize the Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2.

Sino Biological, Inc. has recently deposited reagents for the Omicron variant, including recombinant proteins to Spike and Nucleocapsid, and antibody products to BEI Resources.

AMSBIO has expanded its range of custom gene editing services to complement its extensive portfolio of off-the-shelf CRISPR/Cas9 products.

Asynt reports upon a new paper that describes how the fReactor flow chemistry system with add-on photochemical flow modules improves synthetic reactions commonly used in the preparation of drug intermediates.

Eppendorf SE has donated 20,000 euros to the European Molecular Biology Laboratory (EMBL) during an online presentation ceremony. The funds are for the EMBL project “Advancement of Women in Science,” which enables women scientists to begin managerial careers in scientific fields.

AMSBIO has established a comprehensive portfolio of high-quality reagents including unique ranges of antibodies, lectins, enzymes, assay kits and standards, backed by in-depth technical support.

Metrohm is excited to announce the opening of a new office in New Jersey. The new facility will house development, production and manufacturing space for Metrohm Group companies Innovative Photonic Solutions and B&W Tek.

Biosynth Carbosynth and JINAN SHENGQUAN GROUP SHARE-HOLDING CO., LTD. announced their acquisition of Kexing Biopharmaceutical Co., Ltd’s raw material factory in Jinan, China.